1-(1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea

Catalog No. :
ACHUJA846
CAS No. :
78491-02-8
Molecular Formula :
C8H14N4O7
Molecular Weight :
278.22

IUPAC Name:1-(1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea

1-(1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$82.00Login to see priceIn stockInquiry
1000g98%$143.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea
IUPAC Name1-(1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)-1,3-bis(hydroxymethyl)urea
MDL No.MFCD03547942
Molecular FormulaC8H14N4O7
Molecular Weight278.22
SMILESO=C(NCO)N(C(C(N1CO)=O)N(CO)C1=O)CO
InChI KeySOROIESOUPGGFO-UHFFFAOYSA-N
SynonymTox21_303365 | FT-0641680 | 1,3-Bis(hydroxymethyl)-5-[1,3-bis(hydroxymethyl)ureido]hydantoin | N-[1,3-Bis(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-N,N inverted exclamation mark -bis(hydroxymethyl)urea | 1-[1,3-bis(hydroxymethyl)-2,5-dioxo-imidazolidin-4
CAS No.78491-02-8
PubChem CID62277

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317
Precautionary Statement(s)
P261-P280

Synthetic Route by SureRoute

1. ACHUJA846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHUJA846 route product structure diagram
    ACHUJA84678491-02-8 In Stock
Inquiry

2. ACHUJA846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHUJA846 route product structure diagram
    ACHUJA84678491-02-8 In Stock
Inquiry

Comments (0)